Halyard Health, Inc. (HYH) Receives $44.00 Average PT from Analysts

Shares of Halyard Health, Inc. (NYSE:HYH) have received a consensus rating of “Buy” from the nine analysts that are currently covering the company, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $44.00.

Several analysts have issued reports on HYH shares. Zacks Investment Research raised shares of Halyard Health from a “sell” rating to a “hold” rating in a research report on Thursday, October 19th. ValuEngine raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, November 4th. BidaskClub raised shares of Halyard Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 19th. Deutsche Bank AG upped their price target on shares of Halyard Health from $35.00 to $42.00 and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Finally, TheStreet lowered shares of Halyard Health from a “b-” rating to a “c+” rating in a research report on Monday, October 30th.

Several large investors have recently added to or reduced their stakes in HYH. Teachers Advisors LLC increased its holdings in shares of Halyard Health by 1.5% in the first quarter. Teachers Advisors LLC now owns 83,319 shares of the medical instruments supplier’s stock valued at $3,174,000 after purchasing an additional 1,249 shares during the last quarter. Thrivent Financial For Lutherans grew its stake in shares of Halyard Health by 10.2% in the first quarter. Thrivent Financial For Lutherans now owns 8,847 shares of the medical instruments supplier’s stock valued at $337,000 after acquiring an additional 820 shares in the last quarter. Renaissance Technologies LLC acquired a new position in shares of Halyard Health in the first quarter valued at about $727,000. Credit Suisse AG grew its stake in shares of Halyard Health by 4.8% in the first quarter. Credit Suisse AG now owns 84,727 shares of the medical instruments supplier’s stock valued at $3,227,000 after acquiring an additional 3,917 shares in the last quarter. Finally, Teachers Retirement System of The State of Kentucky grew its stake in shares of Halyard Health by 24.2% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 9,440 shares of the medical instruments supplier’s stock valued at $360,000 after acquiring an additional 1,840 shares in the last quarter. Hedge funds and other institutional investors own 91.29% of the company’s stock.

Halyard Health (NYSE HYH) remained flat at $$46.67 during midday trading on Monday. The company’s stock had a trading volume of 218,800 shares, compared to its average volume of 349,598. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.13 and a quick ratio of 1.19. Halyard Health has a 1 year low of $35.24 and a 1 year high of $50.99. The stock has a market capitalization of $2,185.86, a P/E ratio of 22.33, a price-to-earnings-growth ratio of 2.52 and a beta of 1.69.

Halyard Health (NYSE:HYH) last posted its quarterly earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.13. Halyard Health had a net margin of 3.52% and a return on equity of 8.65%. The firm had revenue of $401.40 million for the quarter, compared to analyst estimates of $394.54 million. During the same period in the prior year, the firm posted $0.48 earnings per share. The company’s quarterly revenue was up 1.0% compared to the same quarter last year. analysts forecast that Halyard Health will post 2.08 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://sportsperspectives.com/2017/11/23/halyard-health-inc-hyh-receives-44-00-average-pt-from-analysts.html.

About Halyard Health

Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.

Analyst Recommendations for Halyard Health (NYSE:HYH)

Receive News & Ratings for Halyard Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply